ESC 365 - B-Type natriuretic peptide predicts major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry

ESC Premium Access

B-Type natriuretic peptide predicts major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry

Session: Atrial Fibrillation ePosters

Topic: Rhythm Control, Catheter Ablation

Speaker: Doctor T. Kato (Kanazawa, JP)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Takeshi Kato

Kanazawa University, Kanazawa (Japan)

0 follower

172 more presentations in this session

Atrial fibrillation with or without structural abnormalities. Analysis from a nationwide database.

Speaker: Doctor V. Mertz (FR)

Epicardial adipose tissue and atrial fibrillation: guilty as charged or guilty by association?

Speaker: Doctor J. Sousa (Funchal, PT)

Timing and degree of left atrial stunning and reverse functional remodeling following electrical cardioversion in patients with recent onset atrial fibrillation

Speaker: Doctor P. Arvanitis (Uppsala, SE)

Irregular beat-to-beat hemodynamic properties determine left ventricular function during atrial fibrillation

Speaker: Doctor A. Lyon (Maastricht, NL)

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Speaker: Mr M. Nazarzadeh (Oxford, GB)

Access the full session

Atrial Fibrillation ePosters

Speakers: Doctor T. Kato, Doctor V. Mertz, Doctor J. Sousa, Doctor P. Arvanitis, Doctor A. Lyon...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources